Fortrea Holdings FTRE 深 滬
交易中 09-24 11:26:05 美东时间
19.50
-0.020
-0.10%
華盛通- 最 高20.3039
- 今 開19.40
- 成交量 14.72万股
- 最 低 19.295
- 昨 收 19.52
- 總市值 185.45万
- 52周最高 21.39
- 市盈率 靜 --
- 換手率 154.81%
- 52周最低 8.55
- 委 比 77.14%
- 總股本 9.51万
- 歷史最高 41.02
- 量 比 0.32
- 振 幅 5.17%
- 歷史最低 3.97
- 每 手 1
- 風險率 3.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Fortrea Leverages Early Phase Strengths to Accelerate Market Expansion
Fortrea (NASDAQ:FTRE) signed a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials in an all-cash transaction valued at approximately $45 million. The deal significantly enhances Fortrea’s position as a global clinical development partner by strengthening t...
09-03 01:31
美股大行评级 | Palantir、Snap、爵士制药获多家大行上调目标价；潜在涨幅176.34%！巴克莱维持Snap(SNAP)"超配"评级，目标价从15美元上调至16美元
今日重点评级关注：巴克莱：维持Snap"超配"评级，目标价从15美元升至16美元；Canaccord Genuity：维持阿梅雷斯克"买入"评级，目标价从59美元升至62美元
08-05 11:45
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
Barclays Maintains Equal-Weight on Fortrea Holdings, Raises Price Target to $22
Barclays analyst Luke Sergott maintains Fortrea Holdings (NASDAQ:FTRE) with a Equal-Weight and raises the price target from $18 to $22.
07-30 18:46
Fortrea Holdings Q2 Adj. EPS $0.23 Beats $0.18 Estimate, Sales $678.200M Beat $647.465M Estimate
Fortrea Holdings (NASDAQ:FTRE) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.18 by 27.78 percent. This is a 21.05 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $678.200 millio...
07-29 18:31
Fortrea Announces Key Accounting Leadership Transition Plans
Fortrea Holdings Inc. ( ($FTRE) ) has provided an update. On July 8, 2026, Fort...
07-15 15:50
美股大行评级 | 花旗上调苹果、西部数据、希捷科技、超微电脑等目标价；高盛上调蔚来"买入"评级，目标价7美元
今日重点评级关注：HC Wainwright & Co.：维持艾吉纳斯"买入"评级，目标价从23美元升至30美元；富国银行：上调Q32 Bio评级至"超配"，目标价66美元
07-14 11:36
Mizuho Maintains Neutral on Fortrea Holdings, Raises Price Target to $16
Mizuho analyst Ann Hynes maintains Fortrea Holdings (NASDAQ:FTRE) with a Neutral and raises the price target from $13 to $16.
07-13 20:14
分析师解读医疗健康企业：Viridian Therapeutics（VRDN）与Fortrea Holdings Inc.（FTRE）
医疗保健领域两名分析师分别对VRDN（维里迪安治疗公司）、FTRE（富驰控股有限公司）给出看涨评级。 VRDN相关关键数据：上周五收盘价17.90美元，华尔街共...
06-30 10:32
Fortrea Appoints New CFO and Reaffirms 2026 Outlook
The latest update is out from Fortrea Holdings Inc. ( ($FTRE) ). On June 26, 20...
06-27 04:57
